Literature DB >> 19330336

[Favorable response of pulmonary rheumatoid nodule to Rituximab].

T Oqueka1, H Schultz, F Moosig.   

Abstract

Pulmonary rheumatoid nodules can be found in over 4% of patients with rheumatoid arthritis. Diagnostically they have to be differentiated from malignant and infectious processes. The present article describes a case of pulmonary rheumatoid nodule which responded well to Rituximab therapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19330336     DOI： 10.1007/s00393-009-0435-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  5 in total

1.  Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

Authors:  Stanley B Cohen; Paul Emery; Maria W Greenwald; Maxime Dougados; Richard A Furie; Mark C Genovese; Edward C Keystone; James E Loveless; Gerd-Rüdiger Burmester; Matthew W Cravets; Eva W Hessey; Timothy Shaw; Mark C Totoritis
Journal:  Arthritis Rheum       Date:  2006-09

2.  Consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Authors:  J S Smolen; E C Keystone; P Emery; F C Breedveld; N Betteridge; G R Burmester; M Dougados; G Ferraccioli; U Jaeger; L Klareskog; T K Kvien; E Martin-Mola; K Pavelka
Journal:  Ann Rheum Dis       Date:  2006-10-26       Impact factor: 19.103

3.  Pulmonary rheumatoid nodules demonstrating features usually associated with rheumatoid synovial membrane.

Authors:  J Highton; N Hung; P Hessian; M Wilsher
Journal:  Rheumatology (Oxford)       Date:  2007-01-04       Impact factor: 7.580

Review 4.  Lung disease in rheumatoid arthritis.

Authors:  Carlotta Nannini; Jay H Ryu; Eric L Matteson
Journal:  Curr Opin Rheumatol       Date:  2008-05       Impact factor: 5.006

5.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Authors:  Jonathan C W Edwards; Leszek Szczepanski; Jacek Szechinski; Anna Filipowicz-Sosnowska; Paul Emery; David R Close; Randall M Stevens; Tim Shaw
Journal:  N Engl J Med       Date:  2004-06-17       Impact factor: 91.245
  5 in total
  1 in total

1.  [Regression of peripheral and pulmonary rheumatoid nodules under therapy with rituximab].

Authors:  M G Braun; P Wagener
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.